2017 annual financial data
Adaptive Biotechnologies 2017 Operating cash flow
Direct answer
Operating cash flow was -34,858,000 USD.
Operating income was -44,475,000 USD and net income was -42,831,000 USD.
Operating cash flow was -34,858,000 USD.
Get free Adaptive Biotechnologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 38,448,000 USD
- Operating income
- -44,475,000 USD
- Net income
- -42,831,000 USD
- Operating cash flow
- -34,858,000 USD